shutterstock_309001163_bill_perry
Bill Perry / Shutterstock.com
20 May 2020AmericasRory O'Neill

Cochlear's $268m damages bill stands, says Fed Circuit

Australian ear implants manufacturer  Cochlear must pay $268 million for infringing a patent owned by a US medical research organisation.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
5 June 2020   The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board.
Medtech
19 August 2020   Hearing implant manufacturer Cochlear has agreed to pay an additional $75 million to settle a patent infringement case if an original $268 million damages bill is upheld by the US Supreme Court.
Americas
26 August 2021   Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.

More on this story

Americas
5 June 2020   The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board.
Americas
26 August 2021   Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.
Medtech
19 August 2020   Hearing implant manufacturer Cochlear has agreed to pay an additional $75 million to settle a patent infringement case if an original $268 million damages bill is upheld by the US Supreme Court.

More on this story

Americas
5 June 2020   The US Court of Appeals for the Federal Circuit has said it cannot award attorneys’ fees for proceedings before the US Patent Trial and Appeal Board.
Americas
26 August 2021   Kite Pharma has successfully persuaded the US Court of Appeals for the Federal Circuit to reverse a $1.2 billion win for the Bristol-Meyers Squibb owned Juno Therapeutics over a cancer treatment patent.
Medtech
19 August 2020   Hearing implant manufacturer Cochlear has agreed to pay an additional $75 million to settle a patent infringement case if an original $268 million damages bill is upheld by the US Supreme Court.